As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.
The China diabetes market size reached a value of almost USD 3.6 billion in the year 2020. The market is further expected to grow at a CAGR of 9.5% between 2021 and 2026 to reach a value of almost USD 6.2 billion by 2026.
The China diabetes market is driven by numerous healthcare reforms. Currently, the country represents one of the largest diabetic populations across the globe. China has about 11% of the global adult diabetic population (according to the International Diabetes Federation), due to the increase of more than nine-fold increase in cases within a generation. This can be attributed to the unhealthy eating patterns, hectic lifestyle, significant economic growth, and lack of physical activity, accelerating the population of overweight and obese people in the country.
Diabetes is referred to as a chronic disease that adversely impacts the body's ability to generate adequate insulin, break down the sugar present in food, or use insulin efficiently. It can lead to premature death or severe complications, such as amputation, stroke, and kidney and heart diseases. Diabetes is mainly categorized into three types, such as type 1, type 2, and gestational diabetes.
The China diabetes market is bifurcated on the basis of segment into:
Currently, insulin holds the majority of the total market share due to the increasing number of production facilities across China. The manufacturers produce and supply insulin pumps, along with other insulin delivery systems throughout the country.
The major regional markets for the product include Shanghai, Zhejiang, Guangdong, Jiangsu, and Beijing, among others.
The China diabetes market is driven by the higher vulnerability of Chinese people to diabetes as compared to Europeans. The industry is further aided by the unawareness regarding health issues, considerable consumption of white rice, and poor healthcare infrastructure in the country, which represent some of the major significant factors driving the incidences of diabetes. Thus, the Chinese government is introducing several healthcare reforms, which is invigorating the diabetes industry growth. For instance, it is encouraging foreign investments and permitting multinational companies (MNCs) to extend their services within China. This has helped patients to diagnose diabetes at the early stage and manage it properly. Also, several drug manufacturers in China are focusing on expanding their budget for research and development (R&D) activities in the industry to develop innovative drugs. This trend, along with the highly developed pharmaceutical industry within China, is contributing to the industry growth in the country.
The report gives a detailed analysis of the following key players in the China diabetes market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
The comprehensive EMR report provides an in-depth assessment of the industry based on the Porter's five forces model along with giving a SWOT analysis.
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
7 Industry Opportunities and Challenges
8 China Diabetes Epidemiology
8.1 Diabetes Population and Prevalence Rates
8.2 Population and Prevalence Rates by Diabetes Type (Type-1 and Type-2)
8.3 Population and Prevalence Rates by Region
8.4 Population and Prevalence Rates by Age Group
9 China Diabetes Market Analysis
9.1 Key Industry Highlights
9.2 China Diabetes Historical Market (2016-2020)
9.3 China Diabetes Market Forecast (2021-2026)
9.4 China Diabetes Market by Segment
9.4.1 China Oral Antidiabetics Market
18.104.22.168 Market Share
22.214.171.124 Historical Trend (2016-2020)
126.96.36.199 Forecast Trend (2021-2026)
188.8.131.52 Market by Class
184.108.40.206 Market Share by Key Players
9.4.2 China Insulin Market
220.127.116.11 Market Share
18.104.22.168 Historical Trend (2016-2020)
22.214.171.124 Forecast Trend (2021-2026)
126.96.36.199 Market by Class
188.8.131.52 Market Share by Key Players
9.5 China Diabetes Market by Region
9.5.1 Market Share
10 Regional Analysis
10.1.1 Historical Trend (2016-2020)
10.1.2 Forecast Trend (2021-2026)
10.2.1 Historical Trend (2016-2020)
10.2.2 Forecast Trend (2021-2026)
10.3.1 Historical Trend (2016-2020)
10.3.2 Forecast Trend (2021-2026)
10.4.1 Historical Trend (2016-2020)
10.4.2 Forecast Trend (2021-2026)
10.5.1 Historical Trend (2016-2020)
10.5.2 Forecast Trend (2021-2026)
11 Market Dynamics
11.1 SWOT Analysis
11.2 Porter’s Five Forces Analysis
11.2.1 Supplier’s Power
11.2.2 Buyers Power
11.2.3 Threat of New Entrants
11.2.4 Degree of Rivalry
11.2.5 Threat of Substitutes
11.3 EMR’s Key Indicators for Demand
11.4 EMR’s Key Indicators for Price
12 Value Chain Analysis
13 Competitive Landscape
13.1 Market Structure
13.2 Key Players’ Market Share
13.3 Company Profiles (*This list is only indicative. The report contains a more comprehensive list of players.)
184.108.40.206 Company Overview
220.127.116.11 Demographic Reach and Achievements
18.104.22.168 Company Overview
22.214.171.124 Demographic Reach and Achievements
14 Industry Events and Developments
List of Figures and Tables
1. China Diabetes Market: Key Industry Highlights, 2016 and 2026
2. China Diabetes Epidemiology: Diabetes Population and Prevalence Rates
3. China Diabetes Epidemiology: Population and Prevalence Rates by Diabetes Type (Type-1 and Type-2)
4. China Diabetes Epidemiology: Population and Prevalence Rates by Region
5. China Diabetes Epidemiology: Population and Prevalence Rates by Gender
6. China Diabetes Epidemiology: Population and Prevalence Rates by Age Group
7. China Diabetes Historical Market: Breakup by Segment (USD Billion), 2016-2020
8. China Diabetes Market Forecast: Breakup by Segment (USD Billion), 2021-2026
9. China Diabetes Historical Market: Breakup by Region (USD Billion), 2016-2020
10. China Diabetes Market Forecast: Breakup by Region (USD Billion), 2021-2026
11. China Diabetes Market Structure
In 2020, the China diabetes market attained a value of nearly USD 3.6 billion.
The market is projected to grow at a CAGR of 9.5% between 2021 and 2026.
The market is estimated to grow in the forecast period of 2021-2026 to reach about USD 6.2 billion by 2026.
The major drivers of the industry, such as unhealthy eating patterns and hectic lifestyles, rising disposable incomes, the growing population of overweight and obese, significant consumption of white rice, and introduction of various healthcare reforms by the government are expected to aid the market growth.
The key trend guiding the growth of the diabetes industry include increased investment for research and development (R&D) activities by the government and private organisations to innovate new drugs and growing technological advancements.
The major regions in the industry are Shanghai, Zhejiang, Guangdong, Jiangsu, and Beijing.
Insulin is the leading diabetes segment in the industry.
The major players in the industry are Abbott, and Medtronic, among others.
The China diabetes market attained a value of USD 3.6 billion in 2020 driven by the considerable consumption of white rice and the implementation of favourable government policies to develop the healthcare sector in the region. Aided by increased funding towards research and development (R&D) activities and development of new drugs, the market is expected to witness a further growth in the forecast period of 2021-2026, growing at a CAGR of 9.5%. The industry is projected to reach USD 6.2 billion by 2026.
EMR's meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on its segment, the diabetes industry in China can be bifurcated into antidiabetics and insulin markets, with the insulin segment accounting for the largest market share. The major regional markets for diabetes in China are Shanghai, Zhejiang, Guangdong, Jiangsu, and Beijing. The key players in the above market include Abbott, and Medtronic, among others.
EMR's research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with industry insights that are accurate, actionable, and help them remain ahead of their competition.
Single User License
Five User License
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.